ProfileGDS4095 / 222026_at
TitleTamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OrganismHomo sapiens


SRC1 knockdown control tamoxifen untreated tamoxifen untreated GSM709767 GSM709769 GSM709765 GSM709771 GSM709772 GSM709775 GSM709764 GSM709766 GSM709768 GSM709777 GSM709770 GSM709773 GSM709774 GSM709776 71% 72% 73% 72% 72% 73% 77% 75% 74% 75% 73% 76% 74% 75% sort by genotype/variation sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM709767LY2 SRC1-siRNA tamoxifen treated rep16.9130471
GSM709769LY2 SRC1-siRNA tamoxifen treated rep37.1455572
GSM709765LY2 SRC1-siRNA untreated rep37.5114573
GSM709771LY2 SRC1-siRNA untreated rep17.253372
GSM709772LY2 SRC1-siRNA untreated rep27.142472
GSM709775LY2 SRC1-siRNA untreated rep47.4408673
GSM709764LY2 control-siRNA tamoxifen treated rep28.1311877
GSM709766LY2 control-siRNA tamoxifen treated rep37.8300775
GSM709768LY2 control-siRNA tamoxifen treated rep17.7352874
GSM709777LY2 control-siRNA tamoxifen treated rep47.7907775
GSM709770LY2 control-siRNA untreated rep37.5463273
GSM709773LY2 control-siRNA untreated rep17.985576
GSM709774LY2 control-siRNA untreated rep27.718374
GSM709776LY2 control-siRNA untreated rep47.7429375